4D Molecular Therapeutics (FDMT) Institutional Ownership

$9.53 +0.26 (+2.80%)

Closing price 04:00 PM Eastern

Extended Trading

$9.28 -0.25 (-2.67%)

As of 05:05 PM Eastern

Compare

Current Institutional Ownership Percentage: 99.27%
Number of Institutional Buyers (last 12 months): 84
Total Institutional Inflows (last 12 months): $118.12M

Number of Institutional Sellers (last 12 months): 41
Total Institutional Outflows (last 12 months): $37.60M

Get FDMT Insider Trade Alerts

Want to know when executives and insiders are buying or selling 4D Molecular Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FDMT Institutional Buying and Selling by Quarter

4D Molecular Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2026	Bank of America Corp DE	974,173	$9.07M	0.0%	+17.0%	1.863%
5/19/2026	Janus Henderson Group PLC	5,247,151	$48.87M	0.0%	+13.2%	10.037%
5/18/2026	Exome Asset Management LLC	130,564	$1.22M	0.6%	N/A	0.250%
5/16/2026	Quantinno Capital Management LP	43,525	$405K	0.0%	-6.0%	0.083%
5/15/2026	Rangeley Capital LLC	31,465	$293K	0.3%	-18.6%	0.060%
5/14/2026	Renaissance Technologies LLC	578,265	$5.38M	0.0%	+12.7%	1.106%
5/14/2026	Sei Investments Co.	12,862	$120K	0.0%	+8.9%	0.025%
5/7/2026	Dimensional Fund Advisors LP	522,823	$4.86M	0.0%	+77.3%	1.000%
5/5/2026	Bank of New York Mellon Corp	133,607	$1.24M	0.0%	-2.3%	0.256%
4/27/2026	Simplify Asset Management Inc.	70,430	$656K	0.0%	N/A	0.138%
Get the Latest News and Ratings for FDMT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
4/27/2026	Y Intercept Hong Kong Ltd	25,420	$237K	0.0%	N/A	0.050%
4/20/2026	Assenagon Asset Management S.A.	83,333	$776K	0.0%	-71.9%	0.163%
3/17/2026	Rockefeller Capital Management L.P.	18,054	$135K	0.0%	+14,343.2%	0.032%
2/19/2026	Invesco Ltd.	153,142	$1.15M	0.0%	+21.0%	0.268%
2/18/2026	XTX Topco Ltd	65,022	$488K	0.0%	+62.6%	0.114%
2/18/2026	Virtus Investment Advisers LLC	24,541	$184K	0.1%	N/A	0.043%
2/18/2026	Wellington Management Group LLP	130,252	$977K	0.0%	-3.9%	0.228%
2/18/2026	Susquehanna Portfolio Strategies LLC	10,310	$77K	0.0%	N/A	0.018%
2/18/2026	Tudor Investment Corp ET AL	31,815	$239K	0.0%	+23.5%	0.056%
2/18/2026	Polymer Capital Management US LLC	18,035	$135K	0.0%	N/A	0.032%
2/18/2026	RTW Investments LP	475,737	$3.57M	0.0%	N/A	0.833%
2/18/2026	Millennium Management LLC	96,364	$723K	0.0%	-91.6%	0.169%
2/18/2026	Man Group plc	27,034	$203K	0.0%	+46.2%	0.047%
2/18/2026	Janus Henderson Group PLC	4,635,875	$34.73M	0.0%	+164.4%	8.115%
2/18/2026	Engineers Gate Manager LP	74,269	$557K	0.0%	N/A	0.130%
2/18/2026	Evergreen Quality Fund GP Ltd.	951,474	$7.14M	0.1%	N/A	1.665%
2/18/2026	Baker BROS. Advisors LP	475,737	$3.57M	0.0%	N/A	0.833%
2/18/2026	Armistice Capital LLC	1,936,000	$14.52M	0.2%	+76.6%	3.389%
2/17/2026	ADAR1 Capital Management LLC	116,712	$875K	0.1%	+598.4%	0.204%
2/17/2026	Schonfeld Strategic Advisors LLC	161,982	$1.22M	0.0%	-9.5%	0.284%
2/17/2026	Burkehill Global Management LP	275,000	$2.06M	0.1%	N/A	0.481%
2/17/2026	Jain Global LLC	40,464	$303K	0.0%	N/A	0.071%
2/17/2026	RA Capital Management L.P.	5,653,211	$42.40M	0.4%	+23.9%	9.895%
2/17/2026	ArrowMark Colorado Holdings LLC	485,389	$3.64M	0.1%	-3.7%	0.850%
2/17/2026	Trexquant Investment LP	13,229	$99K	0.0%	-83.7%	0.023%
2/17/2026	Jump Financial LLC	33,830	$254K	0.0%	N/A	0.059%
2/17/2026	Price T Rowe Associates Inc. MD	38,747	$291K	0.0%	-13.9%	0.068%
2/17/2026	Adage Capital Partners GP L.L.C.	1,235,156	$9.26M	0.0%	+605.8%	2.162%
2/17/2026	ExodusPoint Capital Management LP	39,175	$294K	0.0%	N/A	0.069%
2/17/2026	Graham Capital Management L.P.	50,729	$380K	0.0%	N/A	0.089%
Goldman Sachs just told you what to buy (most people missed it) (Ad) Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free. See the stock positioned to solve AI's biggest power crisis
2/16/2026	Squarepoint Ops LLC	71,721	$538K	0.0%	+53.1%	0.126%
2/16/2026	Barclays PLC	170,639	$1.28M	0.0%	+81.9%	0.299%
2/13/2026	Marshall Wace LLP	27,758	$208K	0.0%	-81.0%	0.049%
2/13/2026	The Manufacturers Life Insurance Company	12,595	$94K	0.0%	-11.8%	0.022%
2/13/2026	Walleye Capital LLC	50,762	$381K	0.0%	N/A	0.089%
2/13/2026	Rafferty Asset Management LLC	83,413	$626K	0.0%	N/A	0.146%
2/13/2026	Charles Schwab Investment Management Inc.	353,391	$2.65M	0.0%	+15.5%	0.619%
2/13/2026	Police & Firemen s Retirement System of New Jersey	9,975	$75K	0.0%	-22.5%	0.017%
2/13/2026	State Street Corp	2,688,880	$20.17M	0.0%	+197.5%	4.707%
2/13/2026	Martingale Asset Management L P	11,775	$88K	0.0%	+12.4%	0.021%
2/13/2026	Wells Fargo & Company MN	46,620	$350K	0.0%	+50.4%	0.082%
2/12/2026	Brooklyn Investment Group	13,318	$102K	0.0%	-66.4%	0.023%
2/12/2026	MetLife Investment Management LLC	25,092	$188K	0.0%	+36.4%	0.044%
2/12/2026	Commonwealth Equity Services LLC	20,009	$150K	0.0%	N/A	0.035%
2/12/2026	Renaissance Technologies LLC	512,900	$3.85M	0.0%	+63.8%	0.898%
2/12/2026	Dimensional Fund Advisors LP	294,841	$2.21M	0.0%	+408.3%	0.516%
2/12/2026	EntryPoint Capital LLC	22,324	$167K	0.1%	N/A	0.039%
2/12/2026	Federated Hermes Inc.	1,609,482	$12.07M	0.0%	+0.9%	2.817%
2/12/2026	Decheng Capital LLC	44,311	$332K	0.0%	-52.2%	0.078%
2/12/2026	Nuveen LLC	158,769	$1.19M	0.0%	+69.0%	0.278%
2/11/2026	Deutsche Bank AG	704,207	$5.28M	0.0%	+29.6%	1.233%
2/11/2026	Landing Point Financial Group LLC	19,000	$142K	0.1%	N/A	0.033%
2/11/2026	Parallel Advisors LLC	17,887	$134K	0.0%	-9.4%	0.031%
2/11/2026	Daiwa Securities Group Inc.	6,370	$48K	0.0%	+3,362.0%	0.011%
2/10/2026	Goldman Sachs Group Inc.	4,302,905	$32.27M	0.0%	+4.2%	7.532%
2/10/2026	AXQ Capital LP	30,755	$231K	0.1%	+138.8%	0.054%
2/10/2026	Impact Partnership Wealth LLC	15,123	$113K	0.0%	+36.5%	0.026%
2/10/2026	Principia Wealth Advisory LLC	53,668	$403K	0.1%	N/A	0.094%
2/9/2026	Geode Capital Management LLC	1,012,025	$7.59M	0.0%	+10.8%	1.771%
2/5/2026	Gabelli Funds LLC	12,000	$90K	0.0%	N/A	0.021%
2/5/2026	DNB Asset Management AS	16,123	$121K	0.0%	-25.5%	0.028%
2/3/2026	Mitsubishi UFJ Asset Management Co. Ltd.	23,845	$175K	0.0%	N/A	0.042%
2/3/2026	Privium Fund Management B.V.	210,000	$1.58M	0.3%	+6.4%	0.368%
2/2/2026	Truist Financial Corp	25,000	$188K	0.0%	N/A	0.044%
1/28/2026	Peapod Lane Capital LLC	268,024	$2.01M	1.7%	-16.8%	0.469%
1/20/2026	Harbor Capital Advisors Inc.	29,716	$223K	0.0%	+149.7%	0.052%
1/9/2026	SG Americas Securities LLC	15,531	$116K	0.0%	N/A	0.027%
1/9/2026	Assenagon Asset Management S.A.	296,199	$2.22M	0.0%	-55.4%	0.518%
1/1/2026	JPMorgan Chase & Co.	513,515	$4.46M	0.0%	-42.2%	0.899%
11/17/2025	Armistice Capital LLC	1,096,000	$9.52M	0.1%	+265.3%	1.918%
11/17/2025	Proficio Capital Partners LLC	20,121	$175K	0.0%	-28.1%	0.035%
11/17/2025	Wexford Capital LP	4,676	$41K	0.0%	N/A	0.008%
11/17/2025	Prelude Capital Management LLC	23,000	$200K	0.0%	+11.1%	0.040%
11/17/2025	Parkman Healthcare Partners LLC	200,000	$1.74M	0.2%	N/A	0.350%
11/17/2025	Millennium Management LLC	1,149,401	$9.99M	0.0%	-22.5%	2.012%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	18,900	$164K	0.0%	-13.9%	0.033%
11/17/2025	Decheng Capital LLC	92,748	$806K	0.1%	-61.3%	0.162%
11/17/2025	Brevan Howard Capital Management LP	16,400	$143K	0.0%	N/A	0.029%
11/17/2025	Bank of America Corp DE	819,266	$7.12M	0.0%	-9.0%	1.434%
11/17/2025	ArrowMark Colorado Holdings LLC	504,115	$4.38M	0.1%	-2.0%	0.882%
Trump's gold order: the announcement they won't put on the front page (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now
11/14/2025	Schonfeld Strategic Advisors LLC	179,075	$1.56M	0.0%	N/A	0.313%
11/14/2025	Creative Planning	37,710	$328K	0.0%	N/A	0.066%
11/14/2025	Raymond James Financial Inc.	471,270	$4.10M	0.0%	+3.5%	0.825%
11/14/2025	Man Group plc	18,488	$161K	0.0%	-86.3%	0.032%
11/14/2025	ADAR1 Capital Management LLC	16,712	$145K	0.0%	N/A	0.029%
11/14/2025	Brooklyn Investment Group	39,586	$344K	0.0%	-30.4%	0.069%
11/14/2025	Two Sigma Investments LP	273,496	$2.38M	0.0%	-48.5%	0.479%
11/14/2025	Bridgeway Capital Management LLC	50,000	$434K	0.0%	+100.0%	0.088%
11/14/2025	Squarepoint Ops LLC	46,837	$407K	0.0%	-11.4%	0.082%
11/13/2025	Sei Investments Co.	11,673	$101K	0.0%	-59.1%	0.025%

FDMT Institutional Ownership - Frequently Asked Questions

During the previous two years, 156 institutional investors and hedge funds held shares of 4D Molecular Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($48.87M), RA Capital Management L.P. ($42.40M), Goldman Sachs Group Inc. ($32.27M), Vanguard Group Inc. ($22.38M), State Street Corp ($20.17M), BVF Inc. IL ($17.18M), and VR Adviser LLC ($16.45M).Learn more on 4D Molecular Therapeutics' institutional investors.

99.27% of 4D Molecular Therapeutics' stock is owned by institutional investors. Learn more on FDMT's institutional investor holdings.

Of the 132 institutional investors that purchased 4D Molecular Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($3.49M), BVF Inc. IL ($1.96M), State Street Corp ($1.82M), Federated Hermes Inc. ($1.68M), Armistice Capital LLC ($1.64M), Millennium Management LLC ($1.55M), and Assenagon Asset Management S.A. ($1.13M).

Institutional investors have bought a total of 15,905,626 shares in the last 24 months. This purchase volume represents approximately $118.12M in transactions.

Of the 41 institutional investors that sold 4D Molecular Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.39M), Redmile Group LLC ($885.07K), JPMorgan Chase & Co. ($749.00K), Assenagon Asset Management S.A. ($580.32K), Decheng Capital LLC ($291.20K), Two Sigma Investments LP ($257.67K), and Vanguard Group Inc. ($161.55K).

Institutional investors have sold a total of 5,214,319 shares in the last 24 months. This volume of shares sold represents approximately $37.60M in transactions.

Related Companies

This page (NASDAQ:FDMT) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

4D Molecular Therapeutics (FDMT) Institutional Ownership

FDMT Institutional Buying and Selling by Quarter

4D Molecular Therapeutics Major Shareholders & Ownership History

FDMT Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

4D Molecular Therapeutics (FDMT) Institutional Ownership

Institutional Ownership Changes (13F Filings) for 4D Molecular Therapeutics (NASDAQ:FDMT)

FDMT Institutional Buying and Selling by Quarter

4D Molecular Therapeutics Major Shareholders & Ownership History

FDMT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of FDMT shares?

What percentage of 4D Molecular Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying 4D Molecular Therapeutics' stock?

How much institutional buying is happening at 4D Molecular Therapeutics?

Which of 4D Molecular Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at 4D Molecular Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools